An overview of angiogenesis in bladder cancer

Purpose of the review: Angiogenesis plays a key role in bladder cancer (BC) pathogenesis. In the last two decades, increasing number of publications depicting a multitude of novel angiogenic molecules and pathways have emerged. The growing complexity necessitates evaluation of the breadth of current knowledge to highlight key findings and guide future research.
Recent findings: Angiogenesis is a dynamic biologic process that is inherently difficult to assess. Clinical assessment of angiogenesis in BCs is advancing with the integration of image analysis systems and dynamic contrast-enhanced and magnetic resonance imaging (DCE-MRI). Tumour associated macrophages (TAMs) significantly influence the angiogenic process and further research is needed to assess their potential as therapeutic targets. A rapidly growing list of non-coding RNAs affect angiogenesis in BCs, partly through modulation of vascular endothelial growth factor (VEGF) activity. Vascular mimicry (VM) has been repeatedly associated with increased tumour aggressiveness in BCs. Standardised assays are needed for appropriate identification and quantification of VM channels.
Summary: This article demonstrates the dynamic and complex nature of the angiogenic process and asserts the need for further studies to deepen our understanding.